News

For 61 years, there has been one constant in Jim Stillwell’s life- his wife. When she was diagnosed with Parkinson’s disease, Jim knew what he needed to do. “I took vows and I meant them,” Jim said. “I do not want my wife in a nursing home. It is my job to take care of her.” It has not always been easy, but Jim’s commitment has never wavered, even when his own health took a scary turn a year ago. “My oncologist in Lansing called it an aggressive form of prostate cancer. That scared me,” Jim said. The pl...

  Breast cancer has always been an important topic of discussion in Rebecca Fritz’s family. “My grandma beat stage four breast cancer, and my mother was first diagnosed at 40,” Rebecca said. Not willing to take any chances, Rebecca started getting annual mammograms as recommended by the American Cancer Society , 10 years before the age her mother was diagnosed.   “When I went into McLaren Imaging for my last regular mammogram, they had me fill out a questionnaire about risk factors,” Rebecca s...

Your genes play a meaningful role in your health—shaping everything from your physical features to your risk for certain medical conditions, including cancer. While most cancers are not inherited, about 5% to 10% of cases can be linked to hereditary factors. If cancer has touched your family, learning more about your genetic risk can be an important step toward protecting your future. There is a lot of information online about genetics and cancer, and trying to sort through it by yourself can feel overw...

WDIV Catching breast cancer early, before it spreads, gives patients better treatment options and outcomes. Hadeel Assad, M.D. , medical oncologist, co-leader of the  Breast Cancer Multidisciplinary Team  (MDT), member of the  Phase I Clinical Trials MDT , joined Local 4’s Live in the D to talk about breast cancer screening, advancements in treating breast cancer, clinical trials and why women should get a second opinion when they are diagnosed with breast cancer. Watch the interview here .

Leslie Cameron Devereaux’s memory lives on at the Barbara Ann Karmanos Cancer Institute in her father’s name, Richard C. Devereaux. Upon her death, she gave a lasting gift that will allow Karmanos cancer researchers to move the needle forward in the treatment of lung cancer. The Richard C. Devereaux Foundation donation has made possible the establishment of the Richard C. Devereaux Foundation Endowed Chair for Lung Cancer Research at Karmanos Cancer Institute, which was awarded to Hirva Mamdani, M.D. , ...

The Barbara Ann Karmanos Cancer Institute welcomes Khalil Choucair, M.D., MSc , medical oncologist, to the Thoracic Oncology and Phase I Clinical Trials Multidisciplinary Teams (MDT). Dr. Choucair joins the team after completing his hematology and oncology clinical fellowship at Karmanos, where he served as chief fellow and worked closely with Karmanos oncologists and scientific researchers. He began seeing patients in July 2025 at Karmanos Cancer Center in Detroit and Karmanos Cancer Institute – Dearbo...

WSGW Pancreatic cancer is the third deadliest cancer in the U.S. There is no recommended screening for people at average risk, so it is important to understand the modifiable and non-modifiable factors, including conditions, genetic mutations and syndromes, that can lead to a higher risk of developing this disease. Wasif Saif, M.D., MBBS , medical oncologist and co-leader of the  Gastrointestinal and Neuroendocrine Oncology Multidisciplinary Team  at Karmanos, joined the Art Lewis Show to disc...

(From left to right, Stuart E. Raider, MJSF president; Jeffrey Zonder, M.D.; and Don Rudick, former MJSF director) The Barbara Ann Karmanos Cancer Institute holds a special place in the hearts of those who have been touched by its life-saving mission. Thanks to the community's philanthropic support, Karmanos continues to pursue groundbreaking research that fulfills our promise to provide every patient with the best chance. At this year’s 34 th Annual Hank Greenberg Memorial Golf, Tennis and Pickleball I...

A major new review published in the high-impact Nature journal Signal Transduction and Targeted Therapy (impact factor >50) is reshaping the conversation around KRAS, one of the most historically “undruggable” oncogenes in human cancer. The article, “ Targeting KRAS mutations: orchestrating cancer evolution and therapeutic challenges ,” led by researchers at the Barbara Ann Karmanos Cancer Institute and Wayne State University, has rapidly gained international attention, becoming one of the most acces...

Prevention A new study finds that women who do not get their first mammogram as the guidelines indicate will continue to miss further screenings and have a 40% higher risk of dying from breast cancer. Eric Brown, M.D. , breast surgeon and co-leader of the Breast Cancer Multidisciplinary Team (MDT), and Alit Yousf, M.D., diagnostic radiologist, director of breast imaging and member of the Breast Cancer MDT at Karmanos, comment on the study and outline exactly when women should begin breast cancer screeni...